# Systolic Hypertension in Europe Placebo-Controlled Trial

> **NCT02088450** · PHASE2 · TERMINATED · sponsor: **KU Leuven** · enrollment: 4695 (actual)

## Conditions studied

- Isolated Systolic Hypertension

## Interventions

- **DRUG:** Active treatment with nitrendipine (10-40 mg/day).

## Key facts

- **NCT ID:** NCT02088450
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1990-02
- **Primary completion:** 1997-02
- **Final completion:** 1997-02
- **Target enrollment:** 4695 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088450, "Systolic Hypertension in Europe Placebo-Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02088450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*